Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
U.S. Physical Therapy, Inc is a medical care facilities business based in the US. U-SPhysical Therapy shares (USPH) are listed on the NYSE and all prices are listed in US Dollars. U-SPhysical Therapy employs 3,200 staff and has a trailing 12-month revenue of around USD$422.8 million.
|Latest market close||USD$120.25|
|52-week range||USD$45.13 - USD$133.6496|
|50-day moving average||USD$112.0953|
|200-day moving average||USD$91.6629|
|Wall St. target price||USD$109.25|
|Dividend yield||USD$1.28 (1.05%)|
|Earnings per share (TTM)||USD$2.35|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-08)||N/A|
|1 month (2020-12-15)||N/A|
|3 months (2020-10-15)||N/A|
|6 months (2020-07-15)||N/A|
|1 year (2020-01-15)||N/A|
|2 years (2019-01-15)||N/A|
|3 years (2018-01-15)||N/A|
|5 years (2016-01-15)||N/A|
Valuing U-SPhysical Therapy stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of U-SPhysical Therapy's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
U-SPhysical Therapy's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 51x. In other words, U-SPhysical Therapy shares trade at around 51x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
U-SPhysical Therapy's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 6.9404. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into U-SPhysical Therapy's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
U-SPhysical Therapy's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$64.2 million.
The EBITDA is a measure of a U-SPhysical Therapy's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$422.8 million|
|Operating margin TTM||12.64%|
|Gross profit TTM||USD$112.5 million|
|Return on assets TTM||5.86%|
|Return on equity TTM||11.72%|
|Market capitalisation||USD$1.6 billion|
TTM: trailing 12 months
There are currently 755,566 U-SPhysical Therapy shares held short by investors – that's known as U-SPhysical Therapy's "short interest". This figure is 15.2% down from 891,218 last month.
There are a few different ways that this level of interest in shorting U-SPhysical Therapy shares can be evaluated.
U-SPhysical Therapy's "short interest ratio" (SIR) is the quantity of U-SPhysical Therapy shares currently shorted divided by the average quantity of U-SPhysical Therapy shares traded daily (recently around 67042.236024845). U-SPhysical Therapy's SIR currently stands at 11.27. In other words for every 100,000 U-SPhysical Therapy shares traded daily on the market, roughly 11270 shares are currently held short.
However U-SPhysical Therapy's short interest can also be evaluated against the total number of U-SPhysical Therapy shares, or, against the total number of tradable U-SPhysical Therapy shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case U-SPhysical Therapy's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 U-SPhysical Therapy shares in existence, roughly 60 shares are currently held short) or 0.0725% of the tradable shares (for every 100,000 tradable U-SPhysical Therapy shares, roughly 73 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against U-SPhysical Therapy.
Find out more about how you can short U-SPhysical Therapy stock.
Dividend payout ratio: 14.68% of net profits
Recently U-SPhysical Therapy has paid out, on average, around 14.68% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.05% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), U-SPhysical Therapy shareholders could enjoy a 1.05% return on their shares, in the form of dividend payments. In U-SPhysical Therapy's case, that would currently equate to about $1.28 per share.
While U-SPhysical Therapy's payout ratio might seem low, this can signify that U-SPhysical Therapy is investing more in its future growth.
U-SPhysical Therapy's most recent dividend payout was on 17 April 2020. The latest dividend was paid out to all shareholders who bought their shares by 12 March 2020 (the "ex-dividend date").
U-SPhysical Therapy's shares were split on a 3:2 basis on 29 June 2001. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your U-SPhysical Therapy shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for U-SPhysical Therapy shares which in turn could have impacted U-SPhysical Therapy's share price.
Over the last 12 months, U-SPhysical Therapy's shares have ranged in value from as little as $45.13 up to $133.6496. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while U-SPhysical Therapy's is 1.4236. This would suggest that U-SPhysical Therapy's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company provides industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of October 9, 2020, it operated 549 outpatient physical therapy clinics in 39 states; and managed 38 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. The company was founded in 1990 and is based in Houston, Texas.
Steps to owning and managing DRIO, with 24-hour and historical pricing before you buy.
Steps to owning and managing CYBR, with 24-hour and historical pricing before you buy.
Steps to owning and managing CHCI, with 24-hour and historical pricing before you buy.
Steps to owning and managing CIGI, with 24-hour and historical pricing before you buy.
Steps to owning and managing CKX, with 24-hour and historical pricing before you buy.
Steps to owning and managing CHA, with 24-hour and historical pricing before you buy.
Steps to owning and managing CTHR, with 24-hour and historical pricing before you buy.
Steps to owning and managing CNBKA, with 24-hour and historical pricing before you buy.
Steps to owning and managing CATM, with 24-hour and historical pricing before you buy.
Steps to owning and managing CRME, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.